Bart, Stephan <br/><br/>
Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study.  [electronic resource] 

 -  Human vaccines & immunotherapeutics  09 2016 
 - 2278-88 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2164-554X 
<br/><br/><label>Standard No.: </label>10.1080/21645515.2016.1182270  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antibodies, Viral--blood<br/>Cell Culture Techniques<br/>Double-Blind Method<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Female<br/>Hemagglutination Inhibition Tests<br/>Humans<br/>Influenza Vaccines--administration & dosage<br/>Male<br/>Middle Aged<br/>Technology, Pharmaceutical<br/>Young Adult